Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA study

Giovanni Cioffi; Pompilio Faggiano; Donata Lucci; Aldo Maggioni; Valeria Manicardi; Augusto Travaglini; Daniela Girfoglio; Serge Masson; Carlo Giorda; Mario Velussi; Andrea Di Lenarda; Paolo Verdecchia; Marco Comaschi

doi:10.1016/j.diabres.2013.05.010

Related publications

Article2020

Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trial

Giovanni Cioffi, Carlo Giorda, Donata Lucci, Elisa Nada, Federica Ognibeni, Costantino Mancusi, Roberto Latini, Aldo Maggioni

Article2011

Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study

Carlo Giorda, Giovanni Cioffi, Giovanni de Simone, Andrea Di Lenarda, Pompilio Faggiano, Roberto Latini, Donata Lucci, Aldo Maggioni, Luigi Tarantini, Mario Velussi, Paolo Verdecchia, Marco Comaschi

Article2011

Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study

Giovanni Cioffi, Carlo Giorda, Marcello Chinali, Andrea Di Lenarda, Pompilio Faggiano, Donata Lucci, Aldo Maggioni, Serge Masson, Gian Francesco Mureddu, Luigi Tarantini, Mario Velussi, Marco Comaschi

Article2008

Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes

Piero Ruggenenti, Ilian Iliev, Grazia Maria Costa, Aneliya Parvanova, Annalisa Perna, Giovanni Giuliano, Nicola Motterlini, Bogdan Ene‐Iordache, Giuseppe Remuzzi

Article2014

NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up

Nektaria Papadopoulou‐Marketou, Chrysanthi Skevaki, Ioanna Kosteria, Μelpomeni Peppa, George Chrousos, Ioannis Papassotiriou, Christina Kanaka‐Gantenbein